Princeton Global Asset Management LLC Rigel Pharmaceuticals Inc Transaction History

Princeton Global Asset Management LLC

  • $488 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021
BUY
$3.5 - $4.5 $3,486 - $4,482
996 Added 24900.0%
1,000 $4,000
Q3 2021

Nov 03, 2021
SELL
$3.5 - $4.5 $3,486 - $4,482
-996 Reduced 99.6%
4 $4,000
Q2 2019

Sep 06, 2019
BUY
$2.02 - $2.61 $2,020 - $2,610
1,000 New
1,000 $3,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email